ClinicalTrials.Veeva

Menu

The Molecular Pathogenesis Study of Cataract

E

Eye & ENT Hospital of Fudan University

Status

Enrolling

Conditions

Cataract
Pathogenesis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

To study the molecular pathogenesis of cataract and explore possible treatments,anterior lens capsules were collected from cataract patients

Full description

Anterior lens capsules were collected from the patients with DC and ARC, and transparent crystals of cadaveric eyes. M6A epitranscriptomic microarray was performed to investigate the altered m6A modifications and determine the differentially expressed mRNAs. The potential role of dysregulated m6A modification levels was predicted through Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses. Real-time polymerase chain reaction was performed to identify the dysregulated expression of RNA methyltransferases, demethylases, and readers.

Enrollment

150 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diabetic cataract
  • underwent cataract surgery

Exclusion criteria

  • Combined with other eye diseases
  • underwent other eye surgery

Trial design

150 participants in 3 patient groups

DC group
Description:
Anterior lens capsule tissues from DC patients
ARC group
Description:
Anterior lens capsule tissues from ARC patients
NC group
Description:
anterior lens capsules collected from three age-matched transparent crystals of cadaveric eyes

Trial contacts and locations

1

Loading...

Central trial contact

Lei Cai, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems